Pediatrix Medical Group (NYSE:MD) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Pediatrix Medical Group, Inc. (NYSE:MD) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $20.17 and traded as high as $20.73. Pediatrix Medical Group shares last traded at $20.6090, with a volume of 1,286,465 shares.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on MD. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Monday, December 29th. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on shares of Pediatrix Medical Group in a research report on Friday, February 20th. UBS Group decreased their price objective on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating for the company in a research note on Tuesday, February 24th. Truist Financial cut their target price on Pediatrix Medical Group from $24.00 to $21.00 and set a “hold” rating on the stock in a research note on Thursday, February 19th. Finally, Zacks Research lowered Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Friday, January 23rd. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Pediatrix Medical Group has an average rating of “Hold” and an average target price of $19.80.

Pediatrix Medical Group Stock Up 4.6%

The company has a market capitalization of $1.71 billion, a PE ratio of 10.62 and a beta of 0.79. The stock’s fifty day moving average is $20.65 and its two-hundred day moving average is $20.17. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.66.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Thursday, February 19th. The company reported $0.50 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). The company had revenue of $493.77 million for the quarter, compared to analysts’ expectations of $486.23 million. Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.The business’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter last year, the business posted $0.51 EPS. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Institutional Investors Weigh In On Pediatrix Medical Group

Hedge funds have recently modified their holdings of the stock. Rockefeller Capital Management L.P. lifted its stake in Pediatrix Medical Group by 814.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock valued at $12,713,000 after purchasing an additional 529,367 shares during the last quarter. Invesco Ltd. increased its position in Pediatrix Medical Group by 24.4% in the fourth quarter. Invesco Ltd. now owns 1,090,655 shares of the company’s stock worth $23,329,000 after buying an additional 213,636 shares during the last quarter. State of Tennessee Department of Treasury increased its position in Pediatrix Medical Group by 2.8% in the fourth quarter. State of Tennessee Department of Treasury now owns 46,016 shares of the company’s stock worth $984,000 after buying an additional 1,246 shares during the last quarter. EP Wealth Advisors LLC bought a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at $472,000. Finally, Mackenzie Financial Corp raised its stake in shares of Pediatrix Medical Group by 35.7% in the fourth quarter. Mackenzie Financial Corp now owns 55,150 shares of the company’s stock valued at $1,201,000 after buying an additional 14,502 shares during the period. Institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.